期刊文献+

以单纯血小板减少为首发表现的艾滋病5例分析 被引量:3

下载PDF
导出
摘要 艾滋病(AIDS)是由人类免疫缺陷病毒(HIV)引起的人类获得性免疫缺陷综合征,表现为各种机会性感染及肿瘤,在血液系统中可表现为贫血、白细胞及血小板减少。但有少部分病例是以单纯血小板减少为主要首发临床表现而就诊,经过长时间诊疗未明确病因,进一步检查提示HIV抗体阳性。
出处 《现代医药卫生》 2016年第11期1773-1774,共2页 Journal of Modern Medicine & Health
基金 贵州省卫生计划生育委员会资助项目(gzwkj2010-1-041) 贵阳市科技局资助项目(20111103-25)
  • 相关文献

参考文献9

  • 1周志仙,赵敏.艾滋病诊疗新技术[M].北京:人民军医出版社,2005:395.
  • 2买买提艾力·吾布力,潘珂君,孙晓风,依巴古力·艾拜都拉,张跃新.以血小板减少为主要表现的艾滋病患者临床特点及转归[J].中华医学杂志,2012,92(19):1314-1316. 被引量:3
  • 3Kyeyune R, Saathoff E, Ezeamama AE, et al. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda[J]. BMC Infect Dis, 2014,14:496.
  • 4Ambler KL, Vickars LM, Leger CS, et al. Clinical Features,Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era[J]. Adv Hematol, 2012,2012 : 910954.
  • 5Marks KM ,Clarke RM ,Bussel JB ,et al. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy [J]. J Acquir Immune Defic Syndr, 2009,52 (5) : 595-599.
  • 6Firnhabera C, Smeatonb L, Saukilac N, et al.Comparisons of anemia,throm- bocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa,Asia,and the Americas[J]. Int J Infect Dis ,2010,14 (12) :e1088- 1092.
  • 7Sato T, Sekine H, Kakuda H, et al. HIV infection of megakaryocytic cell lines[J]. Leuk Lymphoma, 2000,36 (324) : 397-404.
  • 8Neunert C, Lim W, Crowther M, et al. The American Society of Hemato- logy 2011 evidence-based practice guideline for immune thrombocytope- nia[J]. Blood, 2011,117 (16) : 4190-207.
  • 9Shindo T, Nishijima T,Teruya K, et al. Combination of high-dose dexam- ethasone and antiretroviral therapy rapidly improved and induced long- term remission of HIV-related thrombocytopenic purpura[J]. J Infect Che- mother,2013,19(6) : 1170-1172.

二级参考文献8

  • 1叶义红,陈卫诚,刘兰,孟江华.艾滋病25例临床分析[J].临床军医杂志,2005,33(4):435-436. 被引量:8
  • 2Carbonara S, Fiorentino G, Serio G, et al. Response of severe HIV-associated thmmbocytopenia to highly active antiretroviral therapy including protease inhibitors. J Infect ,2001,42:251-256.
  • 3Marks KM, Clarke RM, Bussel JB, et al. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr, 2009,52 : 595 -599.
  • 4Moller T, Hasselbalch HC : Hematological changes associated with human immunodeficiency virus ( HIV-1 ) infection. Ugeskr Laeger, 1993,155 : 1442-1446.
  • 5Goedert JJ, Brown DL, Hoots K, et al. Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia. Haemophilia, 2004, 10:205-210.
  • 6姚慧臣.HIV感染的血液学改变[J].临床荟萃,1999,14(12):569-571. 被引量:4
  • 7岳云璇.42例HIV感染/艾滋病患者血液学表现[J].海南医学,2002,13(1):58-59. 被引量:9
  • 8黄梅,路武,徐慧珍.艾滋病的临床及血液学特点[J].内科急危重症杂志,2003,9(4):183-184. 被引量:7

同被引文献18

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部